Significant Decrease in Short Interest for Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)
Oct 12, 2024
Pharmaceuticals Invest Advisor
BridgeBio to Unveil Long-Term Outcomes of Acoramidis Study at AHA 2024
Oct 4, 2024
Dupixent® (dupilumab) Gains Approval in China as Groundbreaking Biologic for COPD Patients
Sep 28, 2024
Alembic Pharma Secures USFDA Approval for Paliperidone Extended-Release Tablets
Sep 28, 2024
Phase 3 Trial of Dupixent® Shows Significant Efficacy in Treating Chronic Spontaneous Urticaria
Sep 11, 2024
Ventyx Biosciences Commences Phase 2a Trial for VTX3232 in Early Parkinson's Disease Patients
Sep 6, 2024
Bharat Biotech's Breakthrough Oral Cholera Vaccine Poised to Impact Global Health
Aug 28, 2024
CDSCO Places 34 Fixed-Dose Combinations Under Scrutiny Amid Market Watch
Aug 24, 2024
XORTX Set to Present at Kidney Week 2024 Hosted by ASN
Aug 20, 2024
Biofil Chemicals & Pharmaceuticals Reports Profit Dip in June 2024 Quarter
Aug 14, 2024
ARS Pharmaceuticals Announces FDA Approval of Needle-Free Epinephrine Spray 'neffy'
Aug 10, 2024
Dr. Reddy's Advances With CHMP's Nod for Rituximab Biosimilar
Jul 30, 2024
Bristol-Myers Squibb (BMY) Exceeds Q2 Earnings Expectations and Raises 2024 EPS Forecast
Jul 26, 2024
UK NHS Faces Unexpected Hurdle in Wegovy Weight-Loss Drug Rollout Due to Clinic Shortages
Jul 25, 2024
FDA Issues Complete Response Letter to Novo Nordisk for Icodec Insulin
Jul 11, 2024
Amylyx Pharmaceuticals Acquires Drug Candidate Avexitide, Shares Climb
Jul 11, 2024
Arcutis Biotherapeutics Gains FDA Approval for ZORYVE® Cream to Treat Atopic Dermatitis
Jul 10, 2024
Global Losartan Market to Reach $2.3 Billion by 2034, Forecasts Transparency Market Research Inc.
Jul 10, 2024
Groundbreaking INHALE-3 Study Validates Efficacy of Inhaled Insulin for Type 1 Diabetes
Jun 23, 2024
INHALE-3 Study Highlights Superior Efficacy of Inhaled Insulin for T1D Management
Jun 23, 2024
LAVA Provides Business Updates and Announces Q1 2024 Financial Achievements
May 21, 2024
Piramal Pharma Limited Announces Q4 and Fiscal Year 2024 Results
May 12, 2024
Inhibikase Therapeutics Advances with FDA Recognition of IkT-001Pro for Pulmonary Arterial Hypertension Treatment
May 9, 2024
Cingulate Advances in ADHD Treatment Options, Seeks FDA New Drug Application
May 8, 2024
Cognition Therapeutics Announces Completion of Patient Enrollment for Phase 2 SHIMMER Study Evaluating CT1812 in Mild-to-Moderate Lewy Body Dementia
Apr 29, 2024
VELSIPITY™ Granted Health Canada Approval for Ulcerative Colitis Treatment
Apr 25, 2024
Novartis and MMV Unveil Promising Malaria Treatment Data for Infants Under 5 Kilograms
Apr 25, 2024
Idorsia and Viatris Finalize Global R&D Collaboration Deal
Mar 18, 2024
Ventyx Biosciences Announces Positive Clinical Data for NLRP3 Inhibitor and Upcoming Phase 2a Trials
Mar 12, 2024
FDA Approves Wegovy® for Cardiovascular Risk Reduction in Overweight or Obese Patients with Established Heart Disease
Mar 9, 2024
Quoin Pharmaceuticals Stock Surges Following FDA Approval for Teen Participation in Clinical Studies
Mar 5, 2024
Cancer Supportive Care Drugs Market Projected to Reach USD 16.7 Billion by 2031
Feb 12, 2024
The Push for Gentler Cancer Drugs: Balancing Efficacy with Quality of Life
Feb 7, 2024
European Commission Withdraws Approval for Generic TECFIDERA® - Impact on Biogen BIIB
Dec 20, 2023
Narcotic Drugs Market Forecasts a Prominent Growth Amid Rising Chronic Diseases
Dec 19, 2023
Xilio Therapeutics Begins Phase 1 Trial Enrollment for XTX101 in Combination Therapy for Colorectal Cancer
Dec 8, 2023
Novartis Secures FDA Approval for PNH Treatment Fabhalta
Dec 7, 2023
Incannex Healthcare Advances IHL-42X in Phase 2/3 Trials for Sleep Apnea
Dec 7, 2023
The Pursuit of Weight Loss: Evaluating Ozempic Alternatives Amidst Rising Demand
Dec 4, 2023
SciSparc Celebrates Positive Outcomes for MitoCareX Bio Through Proprietary Drug Discovery Platform
Nov 28, 2023
Neumora Therapeutics Embarks on Phase 1 Clinical Study for NMRA-266, Targeting Schizophrenia Treatment
Nov 27, 2023
Connect Biopharma Releases Encouraging Long-Term Results for Rademikibart in Atopic Dermatitis Study
Nov 22, 2023
Tonix Pharmaceuticals Commences Research Coverage Amid Financial Industry Movement
Nov 18, 2023
Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by Analysts at StockNews.com
Nov 18, 2023